News und Analysen
QIAGEN fully acquires NeuMoDx Molecular, Inc., rounding out portfolio of PCR-based diagnostic automation systems
QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the acquisition of the remaining 80.1% of diagnostics instruments company NeuMoDx Molecular, Inc. for $248 million in cash
co.don Aktiengesellschaft beschließt Bezugsrechtskapitalerhöhung gegen Bareinlagen aus Genehmigtem Kapital
NICHT ZUR VERBREITUNG, VERÖFFENTLICHUNG ODER WEITERGABE IN ODER INNERHALB DEN USA, AUSTRALIEN, JAPAN ODER KANADA ODER EINER SONSTIGEN JURISDIKTION, IN DER EINE SOLCHE VERÖFFENTLICHUNG REC
Humana and AtlantiCare Sign Medicare Network Agreement in Southeastern New Jersey
Leading health and well-being company Humana Inc. (NYSE: HUM) has signed an agreement with integrated healthcare system AtlantiCare that offers in-network access for Humana Medicare Advantage
Agilent Expands Line of Innovative Flow Cytometers with the NovoCyte Penteon
Agilent Technologies Inc. (NYSE: A) today announced the launch of the Agilent NovoCyte Penteon, a sensitive flow cytometer with five lasers and up to 30 fluorescence channels. The NovoCyte Penteon
New Data Presented at ESMO Virtual Congress 2020 Highlight Breadth and Potential of Clovis Oncology Products and Pipeline
Clovis Oncology, Inc. (NASDAQ: CLVS) today announced the data being presented as e-posters at the European Society for Medical Oncology (ESMO) Virtual Congress 2020. These include initial data from
True Leaf kündigt Handelsverbot für das Management gemäß National Policy 12-203 an
Vernon (British Columbia), 16. September 2020. True Leaf Brands Inc. (CSE: MJ) (OTCQX: TRLFF) (FWB: TLA) („True Leaf“ oder das „Unternehmen“) gibt bekannt, dass die British Columbia
True Leaf Announces Management Cease Trade Order per National Policy 12-203
Vernon, BC - September 16, 2020 - True Leaf Brands Inc. (CSE: MJ) (OTC Pink: TRLFF) (FSE: TLA) (“True Leaf” or the “Company”) announces that its principal regulator, the British Columbia
Veeva Forms Board Committee to Explore Becoming a Public Benefit Corporation
Veeva Systems (NYSE: VEEV) today announced it has formed a board committee to explore becoming a public benefit corporation (PBC). The Committee will seek input from shareholders, customers, and
Agilent Announces Cash Dividend of 18 Cents Per Share
Agilent Technologies Inc. (NYSE: A) today announced that a quarterly dividend of 18 cents per share of common stock will be paid on Oct. 28, 2020, to all shareholders of record as of the close of
Transgene: Positive Clinical Results for TG4001 and TG6002 and Financial Visibility Secured Until 2022
Regulatory News:
Transgene (Paris:TNG) (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, today publishes its financial
Dexcom Announces First-Ever Registry Dedicated to Tracking Outcomes of In-Hospital Real-Time CGM Use in Response to the COVID-19 Pandemic
DexCom, Inc. (NASDAQ:DXCM), the leader in real-time continuous glucose monitoring (rtCGM) for people with diabetes, announced today the first ever registry dedicated to tracking the outcomes of
IMV CEO to Participate at the Vaccines Panel of the Sachs Associates 20th Annual Biotech in Europe Forum
IMV Inc. (Nasdaq: IMV; TSX: IMV), a clinical-stage biopharmaceutical company pioneering a novel class of cancer immunotherapies and vaccine against infectious diseases, today announced that
More Than 500 Clinical Research Sites Adopt Veeva SiteVault to Accelerate Research
Accelerating clinical research is a top priority across sites, sponsors, and CROs. To help speed research, more sites are using Veeva SiteVault Free for managing study documentation and
True Leaf reicht Antrag auf ein Handelsverbot für das Management ein und berichtet über den aktuellen Stand des Umstrukturierungsprozesses
Vernon (British Columbia), 15. September 2020. True Leaf Brands Inc. (CSE: MJ) (OTCQX: TRLFF) (FWB: TLA) („True Leaf“ oder das „Unternehmen“) gibt heute bekannt, dass das Unternehmen seine
True Leaf Announces Filing of Application for Management Cease Trade Order and Provides Update on Restructuring Process
Vernon, BC - September 15, 2020 - True Leaf Brands Inc. (CSE: MJ) (OTC Pink: TRLFF) (FSE: TLA) (“True Leaf” or the “Company”) announces today that it will miss its filing deadline of
Novus Therapeutics to Present at H.C. Wainwright and Cantor Global Investment Conferences
Novus Therapeutics, Inc. (“Novus”) (NASDAQ: NVUS), a clinical stage biotechnology company targeting the CD40L pathway to develop potential treatments for organ or cell-based transplant, autoimmune
Pfizer Investor Day Features Significant Number of Pipeline Advances for COVID-19 Programs and Across Numerous Therapeutic Areas
As part of a two-day virtual Investor Day, Pfizer Inc. (NYSE: PFE) provided an extensive overview of pipeline advances and shared updates on the Company’s efforts to battle the COVID-19 pandemic on
EnWave unterzeichnet kommerzielles Lizenzabkommen mit Dairy Concepts IRL
Die EnWave Corporation (TSX-V:ENW | FSE:E4U) ("EnWave", oder das "Unternehmen" - https://www.commodity-tv.com/ondemand/companies/profil/enwave-corp/ ) gab heute bekannt, dass sie eine
EnWave Signs Commercial Royalty-Bearing License with Dairy Concepts IRL
Vancouver, B.C., September 15, 2020
EnWave Corporation (TSX-V:ENW | FSE:E4U) (“EnWave”, or the "Company" - https://www.commodity-tv.com/ondemand/companies/profil/enwave-corp/ ), announced
Simulations Plus Releases ADMET Predictor® Version 10.0 (APX)
Simulations Plus, Inc. (Nasdaq: SLP), the leading provider of modeling and simulation solutions for the pharmaceutical, biotechnology, chemicals, and consumer goods industries, today announced that
AstraZeneca Selects Veeva Vault Quality Suite to Modernize Global Quality Management
Veeva Systems (NYSE: VEEV) today announced that AstraZeneca has selected Veeva Vault QMS and Veeva Vault QualityDocs to unify quality management and content on a single cloud platform. Veeva Vault
Antibe Therapeutics to Present at the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit
Antibe Therapeutics Inc. (TSXV: ATE, OTCQB: ATBPF), a clinical stage company leveraging its unique hydrogen sulfide platform to develop safer medicines for pain and inflammation, today announced
GenSight Biologics Submits EU Marketing Authorisation Application for LUMEVOQ® Gene Therapy to Treat Vision Loss Due to Leber Hereditary Optic Neuropathy (LHON)
Regulatory News:
GenSight Biologics (Paris:SIGHT) (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on discovering and developing innovative gene therapies for
VALBIOTIS erhält US-amerikanisches und europäisches Patent für TOTUM-070 zur Verminderung von Hypercholesterinämie
Pflichtmitteilung:
VALBIOTIS (Paris:ALVAL) (FR0013254851 - ALVAL, PEA/SME-qualifiziert), ein Forschungs- und Entwicklungsunternehmen, das sich der wissenschaftlichen Innovation zur Vorbeugung und
Genomic Leaders Collaborate to Create Australia’s First National COVID-19 Tracking System
Illumina (NASDAQ: ILMN) announced today that the Australian public health laboratories will aim to sequence the virus genomes of all positive COVID-19 tests in Australia and track COVID-19 using